Company intelligence / Profile preview

Pharmaprogress

Ownership: Private
Employees: ~28
Development stage: Other

Overview

Pharmaprogress is an Italian contract research organization specializing in the development and validation of analytical methods for pharmaceuticals. It offers GMP-certified laboratory services including finished product testing, impurities identification/testing, raw material testing, stress testing, stability studies under ICH conditions, nitrosamine screening, extractables & leachables analysis. The company was acquired by Kymos Pharma Services in 2016 and now operates as the Italian subsidiary of the Kymos Group[1][2][3].

Modalities: Small moleculeBiologic
Industry: Contract Research Organization

Partnerships

Ipsen

Beyond the preview

Go deeper on Pharmaprogress.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pharmaprogress.

Explore the full profile